| 3.325 -0.105 (-3.06%) | 09-23 09:58 | |||||||||||||
|
|
| Short term | ||||
| Mid term | |
|||
| Targets | 6-month : | 13.95 | 1-year : | 20.83 |
| Resists | First : | 11.94 | Second : | 17.84 |
| Pivot price | 4.23 |
|||
| Supports | First : | 2.42 | Second : | 2.01 |
| MAs | MA(5) : | 3.86 |
MA(20) : | 4.44 |
| MA(100) : | 13.03 |
MA(250) : | 25.69 |
|
| MACD | MACD : | -0.7 |
Signal : | -0.8 |
| %K %D | K(14,3) : | 15.7 |
D(3) : | 18 |
| RSI | RSI(14): 40.6 |
|||
| 52-week | High : | 50.4 | Low : | 2.42 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ TNON ] has closed above bottom band by 27.7%. Bollinger Bands are 43.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 3.98 - 4 | 4 - 4.02 |
| Low: | 3.66 - 3.68 | 3.68 - 3.71 |
| Close: | 3.68 - 3.73 | 3.73 - 3.77 |
Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain. It also provides Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI Joint along its longitudinal axis. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.
Fri, 18 Sep 2026
Tenon Medical (NASDAQ: TNON) raises $4.3M in private deal - Stock Titan
Thu, 17 Sep 2026
HRT FINANCIAL LP Adds Tenon Medical Inc (TNON) Shares -- Stock L - GuruFocus
Wed, 16 Sep 2026
Tenon Medical (TNON) issues 858K new warrants in cash-for-exercise deal - Stock Titan
Tue, 15 Sep 2026
TNON Stock Pops As Tenon Medical Clears Debt Overhang - timothysykes.com
Fri, 11 Sep 2026
Tenon Medical (TNON) Stock Soars Nearly 24% After Hours: Here's Why - webull.com
Fri, 11 Sep 2026
Tenon Medical TNON Stock Jumps As Debt Overhang Fades - timothysykes.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 1 (M) |
| Shares Float | 1 (M) |
| Held by Insiders | 9 (%) |
| Held by Institutions | 5.8 (%) |
| Shares Short | 8 (K) |
| Shares Short P.Month | 14 (K) |
| EPS | -42.75 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -14.57 |
| Profit Margin | -257.9 % |
| Operating Margin | -262.3 % |
| Return on Assets (ttm) | -72 % |
| Return on Equity (ttm) | -551.2 % |
| Qtrly Rev. Growth | 126.8 % |
| Gross Profit (p.s.) | 5.32 |
| Sales Per Share | 7.96 |
| EBITDA (p.s.) | -17.69 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -12 (M) |
| Levered Free Cash Flow | -6 (M) |
| PE Ratio | -0.09 |
| PEG Ratio | 0 |
| Price to Book value | -0.24 |
| Price to Sales | 0.43 |
| Price to Cash Flow | -0.2 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |